CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models
暂无分享,去创建一个
Aleksandra Mojsilovic | Benjamin Hoover | Vijil Chenthamarakshan | Inkit Padhi | Payel Das | Kar Wai Lim | Matteo Manica | Samuel C. Hoffman | Teodoro Laino | Jannis Born | Hendrik Strobelt | A. Mojsilovic | T. Laino | H. Strobelt | Vijil Chenthamarakshan | Matteo Manica | Payel Das | Inkit Padhi | Benjamin Hoover | Jannis Born
[1] Jin Woo Kim,et al. Molecular generative model based on conditional variational autoencoder for de novo molecular design , 2018, Journal of Cheminformatics.
[2] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[3] Nicola De Cao,et al. MolGAN: An implicit generative model for small molecular graphs , 2018, ArXiv.
[4] Thomas Blaschke,et al. Application of Generative Autoencoder in De Novo Molecular Design , 2017, Molecular informatics.
[5] Max Welling,et al. Auto-Encoding Variational Bayes , 2013, ICLR.
[6] Albert-László Barabási,et al. Network-based prediction of drug combinations , 2019, Nature Communications.
[7] Thierry Kogej,et al. Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks , 2017, ACS central science.
[8] Li Li,et al. Optimization of Molecules via Deep Reinforcement Learning , 2018, Scientific Reports.
[9] Cao Xiao,et al. Constrained Generation of Semantically Valid Graphs via Regularizing Variational Autoencoders , 2018, NeurIPS.
[10] Alán Aspuru-Guzik,et al. Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models , 2017, ArXiv.
[11] Niroshini Nirmalan,et al. “Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives , 2016, Proteomes.
[12] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[13] Razvan Pascanu,et al. Learning Deep Generative Models of Graphs , 2018, ICLR 2018.
[14] Jannis Born,et al. PaccMannRL: Designing Anticancer Drugs From Transcriptomic Data via Reinforcement Learning , 2020, RECOMB.
[15] Niloy Ganguly,et al. NeVAE: A Deep Generative Model for Molecular Graphs , 2018, AAAI.
[16] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[17] Steven Skiena,et al. Syntax-Directed Variational Autoencoder for Structured Data , 2018, ICLR.
[18] R. Hilgenfeld,et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors , 2020, Science.
[19] Christopher A. Hunter,et al. Molecular Transformer: A Model for Uncertainty-Calibrated Chemical Reaction Prediction , 2018, ACS central science.
[20] Jürgen Bajorath,et al. Data-Driven Exploration of Selectivity and Off-Target Activities of Designated Chemical Probes , 2018, Molecules.
[21] Alán Aspuru-Guzik,et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors , 2019, Nature Biotechnology.
[22] Yibo Li,et al. Multi-objective de novo drug design with conditional graph generative model , 2018, Journal of Cheminformatics.
[23] Yingyu Liang,et al. N-Gram Graph: Simple Unsupervised Representation for Graphs, with Applications to Molecules , 2018, NeurIPS.
[24] Wu Zhong,et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro , 2020, Cell Discovery.
[25] Thomas Blaschke,et al. Molecular de-novo design through deep reinforcement learning , 2017, Journal of Cheminformatics.
[26] Riccardo Petraglia,et al. Predicting retrosynthetic pathways using transformer-based models and a hyper-graph exploration strategy† , 2020, Chemical science.
[27] Xiaotao Lu,et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease , 2018, mBio.
[28] Hiroshi Kajino,et al. Molecular Hypergraph Grammar with its Application to Molecular Optimization , 2018, ICML.
[29] Antonio Peón,et al. Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target Space , 2017, Scientific Reports.
[30] Kyunghyun Cho,et al. Conditional molecular design with deep generative models , 2018, J. Chem. Inf. Model..
[31] Olexandr Isayev,et al. Deep reinforcement learning for de novo drug design , 2017, Science Advances.
[32] Matt J. Kusner,et al. Grammar Variational Autoencoder , 2017, ICML.
[33] Tao Jiang,et al. A maximum common substructure-based algorithm for searching and predicting drug-like compounds , 2008, ISMB.
[34] Alán Aspuru-Guzik,et al. Reinforced Adversarial Neural Computer for de Novo Molecular Design , 2018, J. Chem. Inf. Model..
[35] John Canny,et al. Evaluating Protein Transfer Learning with TAPE , 2019, bioRxiv.
[36] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[37] Nitish Srivastava,et al. Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..
[38] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[39] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[40] Nikos Komodakis,et al. GraphVAE: Towards Generation of Small Graphs Using Variational Autoencoders , 2018, ICANN.
[41] Ruili Huang,et al. Tox21Challenge to Build Predictive Models of Nuclear Receptor and Stress Response Pathways as Mediated by Exposure to Environmental Chemicals and Drugs , 2016, Front. Environ. Sci..
[42] David Hoksza,et al. PrankWeb: web server for ligand binding-site prediction and visualization , 2019, bioRxiv.
[43] Alexandre Varnek,et al. Estimation of the size of drug-like chemical space based on GDB-17 data , 2013, Journal of Computer-Aided Molecular Design.
[44] Alán Aspuru-Guzik,et al. Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models , 2018, Frontiers in Pharmacology.
[45] Gianni De Fabritiis,et al. From Target to Drug: Generative Modeling for Multimodal Structure-Based Ligand Design. , 2019, Molecular pharmaceutics.
[46] Evan Bolton,et al. PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..
[47] Sepp Hochreiter,et al. Fréchet ChemNet Distance: A Metric for Generative Models for Molecules in Drug Discovery , 2018, J. Chem. Inf. Model..
[48] Regina Barzilay,et al. Junction Tree Variational Autoencoder for Molecular Graph Generation , 2018, ICML.
[49] Petra Schneider,et al. Generative Recurrent Networks for De Novo Drug Design , 2017, Molecular informatics.
[50] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[51] David Hoksza,et al. P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure , 2018, Journal of Cheminformatics.
[52] Bonnie Berger,et al. Learning protein sequence embeddings using information from structure , 2019, ICLR.
[53] Nuno Fernandes,et al. Economic Effects of Coronavirus Outbreak (COVID-19) on the World Economy , 2020, SSRN Electronic Journal.
[54] Daria Grechishnikova,et al. Transformer neural network for protein-specific de novo drug generation as a machine translation problem , 2019, Scientific Reports.
[55] Christophe Meyer,et al. The use of novel selectivity metrics in kinase research , 2017, BMC Bioinformatics.
[56] Richard E. Turner,et al. Sequence Tutor: Conservative Fine-Tuning of Sequence Generation Models with KL-control , 2016, ICML.
[57] Yi Wang,et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial , 2020, The Lancet.
[58] Alán Aspuru-Guzik,et al. Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules , 2016, ACS central science.
[59] Aleksandra Mojsilovic,et al. Accelerating Antimicrobial Discovery with Controllable Deep Generative Models and Molecular Dynamics , 2020, ArXiv.
[60] Vijay S. Pande,et al. MoleculeNet: a benchmark for molecular machine learning , 2017, Chemical science.
[61] Di Wu,et al. DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks , 2018, bioRxiv.
[62] Zacharias E. Andreadakis,et al. The COVID-19 vaccine development landscape , 2020, Nature Reviews Drug Discovery.
[63] George M. Church,et al. Unified rational protein engineering with sequence-based deep representation learning , 2019, Nature Methods.
[64] Lydia E. Kavraki,et al. Prediction of drug metabolites using neural machine translation , 2020 .